title: Change in plasma levels of amino acid neurotransmitters and its correlation with clinical heterogeneity in early Parkinson's disease patients.
abstract: BACKGROUND
  The correlation between plasma amino acid (AA) neurotransmitters and clinical heterogeneity in early patients with Parkinson's disease (PD) is still poorly understood.
  
  
  OBJECTIVE
  To examine the plasma levels of AA neurotransmitters in early patients with PD and to evaluate their correlation with PD subtypes.
  
  
  METHODS
  Based on the predominant symptoms, fifty-one patients with PD were enrolled and divided into four subgroups: (1) akinetic-rigid type (ART), (2) tremor-dominant type (TDT), (3) postural instability/gait difficulty type (PIGD), and (4) mixed type (MT). Plasma levels of AA were measured by HPLC-RF, and their potential diagnostic practicality and their association with PD subtypes were evaluated by the receiver operating characteristic (ROC) and correlation analysis, respectively.
  
  
  RESULTS
  Patients with PD exhibited markedly lower levels of Asp, Glu, Tau, L-ser, and lower values of Glu/GABA ratio than healthy controls. The ROC analysis revealed their high sensitivity (77.1-87.5%) and specificity (58.8-88.2%). Furthermore, the glutamic acid (Glu), γ-aminobutyric acid (GABA) level in the PIGD subtype was increased as compared with other subtypes and was negatively correlated with the ART/PIGD ratio.
  
  
  CONCLUSIONS
  The decrease in plasma Asp, Glu, Tau, L-ser levels, and the value of Glu/GABA ratio may be helpful for early PD diagnosis. The elevated GABA level may be the biochemical basis for the specific symptoms of PIGD PD.
authors: Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
authors: Yong-Sheng
authors: YS
authors: Yuan
authors: Xian-Ju
authors: XJ
authors: Zhou
authors: Qing
authors: Q
authors: Tong
authors: Lei
authors: L
authors: Zhang
authors: Lian
authors: L
authors: Zhang
authors: Zhi-Qiang
authors: ZQ
authors: Qi
authors: Song
authors: S
authors: Ge
authors: Ke-Zhong
authors: KZ
authors: Zhang
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000596:Amino Acids / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000097:blood; D010300:Parkinson Disease / Q000097:blood* / Q000175:diagnosis*; D005680:gamma-Aminobutyric Acid / Q000097:blood*
chemical_list: D000596:Amino Acids; D015415:Biomarkers; D018377:Neurotransmitter Agents; D005680:gamma-Aminobutyric Acid
keywords: Amino acid neurotransmitter; Clinical heterogeneity; Motor subtype; Parkinson's disease
references: Mov Disord. 2000 May;15(3):479-84
references: 10830412
references: NMR Biomed. 2008 May;21(4):381-7
references: 17907264
references: J Neurosci. 2008 Sep 17;28(38):9575-84
references: 18799689
references: J Lab Clin Med. 1971 Feb;77(2):319-25
references: 5540775
references: Biochem Biophys Res Commun. 1997 Jun 9;235(1):26-30
references: 9196029
references: Epilepsy Res. 1999 Apr;34(2-3):145-50
references: 10210029
references: Life Sci. 2012 Jul 26;91(1-2):5-13
references: 22634324
references: Eur J Neurol. 2007 Jul;14(7):721-8
references: 17594326
references: Neurosci Lett. 2008 Jun 13;438(1):10-3
references: 18457923
references: Neurosci Lett. 1992 Oct 12;145(2):175-7
references: 1361223
references: J Psychiatr Res. 1975 Nov;12(3):189-98
references: 1202204
references: Crit Care Med. 2009 Feb;37(2):501-9
references: 19114888
references: Clin Neurophysiol. 2008 Jul;119(7):1459-74
references: 18467168
references: CNS Neurosci Ther. 2011 Dec;17(6):796-8
references: 22117806
references: J Neurol Sci. 1997 Sep 10;150(2):123-7
references: 9268238
references: Ann Surg. 2011 Jan;253(1):27-34
references: 21294285
references: Eur J Pharmacol. 2009 Jan 5;602(1):73-7
references: 19010319
references: J Neurol Neurosurg Psychiatry. 2006 May;77(5):585-9
references: 16614017
references: Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
references: 12498954
references: Brain Res. 2010 Jun 2;1334:45-57
references: 20382131
references: Neurology. 1990 Oct;40(10):1529-34
references: 2215943
references: Mov Disord. 2004 Sep;19(9):1059-64
references: 15372596
references: J Neural Transm (Vienna). 2011 Oct;118(10):1453-60
references: 21448675
references: J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
references: 1564476
references: Sheng Li Xue Bao. 2011 Aug 25;63(4):311-8
references: 21861049
references: J Biol Chem. 2010 Dec 31;285(53):41380-90
references: 20966073
references: Adv Exp Med Biol. 2013;776:105-11
references: 23392875
references: Acad Radiol. 2011 Feb;18(2):235-41
references: 21232687
references: Neurology. 2009 Jul 21;73(3):206-12
references: 19620608
references: J Neurol Neurosurg Psychiatry. 1982 Mar;45(3):253-6
references: 7086446
references: J Sep Sci. 2009 Jan;32(2):282-7
references: 19156646
references: Exp Neurol. 2004 Nov;190(1):145-56
references: 15473988
references: Arch Neurol. 2001 Oct;58(10):1611-5
references: 11594919
references: Mov Disord. 2011 Feb 15;26(3):543-6
references: 21462263
references: Yonsei Med J. 2000 Apr;41(2):167-84
references: 10817016
references: Parkinsonism Relat Disord. 2009 Jun;15(5):379-82
references: 18977165
references: Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:3294-7
references: 19964296
references: Clin Exp Pharmacol Physiol. 2012 Jun;39(6):577-85
references: 22126374
references: Amino Acids. 2014 Jan;46(1):31-46
references: 22903433
references: PLoS One. 2012;7(1):e30918
references: 22295119
references: Neurosci Lett. 2012 Jun 27;520(1):32-7
references: 22583765